A clearly defined procedure for the mandatory hospitalization of citizens who are diagnosed with coronavirus (COVID-19) or are suspected of carrying the virus will prevent possible abuse that may be caused by a restriction of patients’ rights, lawyers interviewed by Interfax-Ukraine have said.
“A clear fixed procedure for involuntary hospitalization, responsibility for violation of the rights of sick people will prevent the abuse that may occur during involuntary hospitalization,” Managing Partner of the Revealing Information Law Firm Oleksandr Keer said.
According to him, the procedure for hospitalization of patients by ambulance teams in medical institutions, approved by order of the Health Ministry No. 370 dated June 1, 2009, provides for the patient’s mandatory consent to hospitalization. At the same time, the law on ensuring sanitary and epidemic well-being of the population establishes that persons with especially dangerous infectious diseases, in case of refusal to be hospitalized, are subject to compulsory inpatient treatment, and carriers of the causative agents of such diseases and persons who have contact with such patients are obliged to be under medical supervision and quarantine in the prescribed manner.
Keyer emphasized that COVID-19 was included in the list of such diseases by order of the Health Ministry dated February 25, 2020.
Meanwhile, the law on the protection of the population from infectious diseases (adopted in 2000) provides that the central executive body, which ensures the formation of state policy in the field of health (Health Ministry), establishes the procedure for hospitalization, treatment and medical monitoring of patients with infectious diseases, contacts and bacterium carriers, as well as the conditions for their stay in relevant healthcare and scientific institutions.
“At present, there is no normative legal act that would determine the procedure for hospitalization, treatment, medical supervision of patients with infectious diseases, except for patients with tuberculosis,” the lawyer said.
Obligatory medical examination and hospitalization of patients with COVID-19 can be carried out on the basis of a corresponding statement of a representative of a medical institution by court decision. However, according to Keyer, the procedure for considering this category of cases will need to be provided for in Ukraine’s Civil Procedure Code to ensure rights, freedoms and interests of sick people.
Ukrainian business continues providing its support in fighting the coronavirus disease COVID-19 pandemic, sending money to crisis response teams or buying artificial lungs ventilators, other equipment and protective equipment for medical workers.
In particular, the RDS group of companies, involved in the construction and operation of roads belonged to Yuriy Shumakher and Yevhen Konovalov, bought the Oricare V8600 artificial lung ventilation machine (the United States) for the city of Odesa, and also provides financial assistance to local authorities for the purchase of protective equipment (masks, disinfectants) in the seven regions where it operates.
Makar Paseniuk and Kostiantyn Stetsenko’s ICU investment group purchased COVID-19 tests and intensive care equipment for Kyiv designated hospitals. In particular, for the Oleksandrivska City Clinical Hospital, which receives the main flow of patients with possible COVID-19 disease, the ICU acquired 200 additional polymerase chain reaction (PCR) tests. The investment group provided the city hospital No. 4, one of the three designated hospitals in Kyiv, with almost 5,000 units of intensive care supplies: virus-bacterial filters, breathing circuits, endotracheal tubes, oxygen masks and drainage bags, and the Kyiv perinatal center received three all-in-one intensive care monitors.
The Regional Gas Company (RGC) of Dmytro Firtash purchased medical equipment, components for it, protective equipment, as well as materials and medicines for the amount of UAH 10 million and plans to send another tranche of assistance. In particular, RGC was able to purchase an artificial lung ventilator and monitors for existing ventilators, 2,000 express tests, 30,000 masks and FFP2respirators, 5,000 special glasses, about 5,000 gowns and special overalls and about 3,000 biosecurity kits, as well as disinfection solutions, medicines and fuel for ambulances.
The P&O Maritime Ukraine towing company transferred UAH 6.8 million to the Odesa crisis response team, and TIS-Grain sent UAH 3 million.
Synevo, part of Sweden’s Medicover holding, has handed over the COVID-19 diagnostic equipment using PCR (Polymerase Chain Reaction) tests – the most reliable method for diagnosing this coronavirus disease, to the Public Health Center, Synevo Development Director Mykola Butenko said at a video press conference at Interfax-Ukraine on Tuesday.
The equipment made by Swiss Roche will allow increasing the speed and the number of COVID-19 tests and will significantly increase the accuracy of test results, removing human element from the process.
The analyzer’s capacities are 96 tests per hour. Different types of biomaterial (blood, saliva, cerebrospinal fluid and others) can be tested.
The equipment has already been delivered by Synevo to the virology reference laboratory of the Public Health Center in Kyiv, which will perform COVID-19 testing.
“In Ukraine, because of the high cost of equipment, this initial stage is usually tested manually by laboratory staff. This limits the speed and number of tests performed. Using the new analyzer will minimize the human factor. As a result, we will significantly increase the number of tests performed and eliminate the risk of human error,” Butenko said.
The use of new equipment will increase the safety of the laboratory staff, since the apparatus performs the process of RNA extraction from the biomaterial automatically, therefore, the laboratory staff will no longer have to contact samples of potentially infected biomaterial.
To launch the analyzer, representatives of Roche Diagnostics in Ukraine will be involved in the startup of the equipment, as well as in special training for employees of the Public Health Center’s laboratory how to use the equipment.
The PCR method directly detects DNA or virus RNA in the biomaterial, therefore this method is the most reliable in the world for the diagnosis of COVID-19.
Biopharma, which is one of the ten largest Ukrainian manufacturers of the pharmaceutical industry and specializes in human blood plasma drugs, has submitted to the laboratories of the Public Health Center of the Ministry of Health of Ukraine equipment that will allow the presence and absence of samples to be determined quickly and by modern methods agents of coronavirus disease. This decision, in conjunction with entrepreneur Vasyl Khmelnytsky’s UFuture holding company, is a continuation of a series of social initiatives undertaken by Ukrainian entrepreneurs amid a coronavirus pandemic.
“The Center will become the main reference site that will monitor the correctness of diagnostics throughout Ukraine. In other words, samples from laboratories will be sent here to confirm or refute the diagnosis. Without the transferred equipment, effective control of coronavirus disease in Ukraine would be defective,” Kostiantyn Yefymenko, President of Biopharma, reported.
The first unit is the Nuclear Acid Extraction Equipment from Thermo Fisher Scitific with consumables for 20,000 samples. The equipment helps prepare samples for analysis. The second unit is the equipment of Bio-Rad CFX 96 for molecular genetic analysis by PCR for the presence of a DNA virus and a system test for the detection of COVID-19.
The total cost of the equipment exceeds six million UAH, its installation and startup is performed by the company “ALT Ukraine LTD”. The equipment allows to process up to 100 samples in 60 minutes and in total about 2 thousand analyzes per day.
“Business should do everything in its power to stop the spread of the coronavirus and bring Ukraine back to normal. First of all, we need quality and timely diagnostics. already hundreds of millions of hryvnias and assistance continues,” Vasyl Khmelnytsky, founder of UFuture, said.
In addition, UFuture purchased two lung ventilation devices and all materials for their operation for the amount of 1 million 700 thousand UAH to one of the hospitals in Kyiv, and Biopharma — equipment for Bila Tserkva city hospital №3 (reference infectious hospital for the Kyiv region) with an amount of five million UAH.
• two AR-203 artificial ventilation apparatus;
• AS-200 biochemical automatic analyzer;
• 3-Part DiffH 18 light hematology analyzer;
• EasyStat blood gas and electrolyte analyzer;
• BM1600 patient monitor with BM200 module;
• Laura Smart urine analyzer;
• two microscopes Micromed Fusion FS-7620.
The total cost of assistance from the holding companies is more than 12 million UAH. Also, masks and systems for rapid tests for the hospitals of Bila Tserkva will be purchased soon.
UFuture is a holding company of Ukrainian entrepreneur Vasyl Khmelnytsky that integrates his business and impact-investment projects. The company has a diversified portfolio of assets in the fields of real estate, infrastructure, industry, renewable energy, pharmaceuticals, and IT. Currently, UFuture’s assets are estimated at $550 million, and the total capitalization of the businesses it invested in is more than $1 billion.
Biopharma is a Ukrainian immunobiological pharmaceutical company that which specializes in the drugs of human blood plasma. The number of employees – more than 300 people. The company exports drugs to 36 countries. In 2019, the company opened in Bila Tserkva a “built from scratch” manufacturing facility, investing about $75 million. Its the only plant of its kind in Eastern Europe.
The European Investment Bank (EIB) is ready to redirect funds issued for programs in Ukraine for fight against coronavirus, Foreign Minister of Ukraine Dmytro Kuleba has said.
“I spoke with the European Investment Bank, which is ready to redirect certain funds allocated for programs in Ukraine to measures to overcome the coronavirus,” he said in an interview with Interfax-Ukraine.
In addition, Kuleba said that at a meeting with the head of the mission of the International Committee of the Red Cross (ICRC) in Ukraine, Florence Gillette, he discussed the question of what kind of help the ICRC can provide to Ukraine in preventing the spread of coronavirus.
“We are ready to receive something as humanitarian aid, to purchase something, but this search is being conducted at all levels, in international organizations, in business contacts,” the minister said.
According to him, the entire system of the Foreign Ministry of Ukraine is now working on two fundamental tasks: the return of Ukrainians from other countries and the search for humanitarian assistance and procurement.